Pegnivacogin (BioDeep_00000182154)

   

human metabolite blood metabolite


代谢物信息卡片


2,6-Bis({[hydroxy(2-methoxyethoxy)methylidene]amino})-N-[6-(phosphonooxy)hexyl]hexanimidate

化学式: C20H40N3O11P (529.240034)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 95.24%

分子结构信息

SMILES: COCCOC(=O)NCCCCC(C(=O)NCCCCCCOP(=O)(O)O)NC(=O)OCCOC
InChI: InChI=1S/C20H40N3O11P/c1-30-13-15-32-19(25)22-11-7-5-9-17(23-20(26)33-16-14-31-2)18(24)21-10-6-3-4-8-12-34-35(27,28)29/h17H,3-16H2,1-2H3,(H,21,24)(H,22,25)(H,23,26)(H2,27,28,29)

描述信息

C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

同义名列表

5 个代谢物同义名

2,6-Bis({[hydroxy(2-methoxyethoxy)methylidene]amino})-N-[6-(phosphonooxy)hexyl]hexanimidate; ({6-[2,6-bis({[(2-methoxyethoxy)carbonyl]amino})hexanamido]hexyl}oxy)phosphonic acid; {6-[2,6-bis({[(2-methoxyethoxy)carbonyl]amino})hexanamido]hexyl}oxyphosphonic acid; RB006 Compound; Pegnivacogin



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Alain Bel, Wasseem Borik, Simon Davidson, Jean-Marie Helies, Lev Stimmer, Stephen Fremes, Steven Zelenkofske, Christopher Rusconi, John Alexander, David Alexander, Philippe Menasché, John Pepper. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2016 Feb; 49(2):682-9. doi: 10.1093/ejcts/ezv159. [PMID: 25953802]
  • Nicklaus T Rice, Fania Szlam, Jeffrey D Varner, Peter S Bernstein, Arthur D Szlam, Kenichi A Tanaka. Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples. PloS one. 2016; 11(5):e0154127. doi: 10.1371/journal.pone.0154127. [PMID: 27196067]
  • Thomas J Povsic, William A Wargin, John H Alexander, Joshua Krasnow, Merill Krolick, Mauricio G Cohen, Roxana Mehran, Christopher E Buller, Christoph Bode, Steven L Zelenkofske, Christopher P Rusconi, Richard C Becker. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. European heart journal. 2011 Oct; 32(19):2412-9. doi: 10.1093/eurheartj/ehr179. [PMID: 21724623]
  • T J Povsic, M G Cohen, M Y Chan, S L Zelenkofske, W A Wargin, R A Harrington, J H Alexander, C P Rusconi, R C Becker. Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design. Journal of thrombosis and thrombolysis. 2011 Jul; 32(1):21-31. doi: 10.1007/s11239-011-0588-3. [PMID: 21503856]
  • Fania Szlam, Deyan Luan, Daniel Bolliger, Arthur D Szlam, Jerrold H Levy, Jeffrey D Varner, Kenichi A Tanaka. Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin. Thrombosis research. 2010 May; 125(5):432-7. doi: 10.1016/j.thromres.2009.11.018. [PMID: 20004955]
  • Kenichi A Tanaka, Fania Szlam, Christopher P Rusconi, Jerrold H Levy. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Thrombosis and haemostasis. 2009 May; 101(5):827-33. doi: 10.1160/th08-06-0341. [PMID: 19404534]